Related Experiment Video

Updated: Aug 22, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus

S A Harding1, A J Sommerfield, J Sarma

  • 1Cardiovascular Research Unit, Royal Infirmary of Edinburgh, Edinburgh EH16 4SB, Scotland, UK.

Atherosclerosis
|September 24, 2004
PubMed

Insights

Type 1 diabetes elevates CD40 ligand expression and platelet-monocyte aggregation, contributing to inflammation and clotting. These findings highlight potential mechanisms driving cardiovascular disease in diabetic patients.

Area of Science:

  • Cardiovascular Research
  • Endocrinology
  • Immunology

Background:

  • Diabetes mellitus is a significant risk factor for cardiovascular disease (CVD).
  • Diabetes is characterized by a proinflammatory and prothrombotic state.
  • Investigating CD40 ligand (L) and platelet-monocyte aggregates in type 1 diabetes is crucial for understanding CVD risk.

Purpose of the Study:

  • To determine if CD40 ligand (L) expression is increased in type 1 diabetes patients.
  • To assess if platelet-monocyte aggregation is elevated in type 1 diabetes.
  • To correlate these markers with glycemic control and inflammation.

Main Methods:

  • Measured serum C-reactive protein (CRP) and soluble CD40L.
  • Assessed platelet surface CD40L expression and platelet-monocyte aggregates.
  • Compared 22 type 1 diabetes patients with 22 matched controls.

Main Results:

  • Type 1 diabetes patients showed higher serum CRP, soluble CD40L, and platelet CD40L expression compared to controls.
  • Platelet-monocyte aggregates were significantly elevated in type 1 diabetes.
  • Plasma glucose correlated positively with CRP and platelet-monocyte aggregates.

Conclusions:

  • Type 1 diabetes is linked to increased CD40L expression and platelet-monocyte aggregation.
  • These factors may promote the proinflammatory and prothrombotic state in diabetes.
  • This contributes to accelerated atherosclerosis in individuals with type 1 diabetes.
Abstract

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...